[{"address1": "200-3650 Gilmore Way", "city": "Burnaby", "state": "BC", "zip": "V5G 4W8", "country": "Canada", "phone": "604 484 3300", "fax": "604 484 3450", "website": "https://www.xenon-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.", "fullTimeEmployees": 316, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.", "age": 48, "title": "Interim CFO, President, CEO, Principal Financial Officer, Principal Accounting Officer & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1184288, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  DiFabio J.D.", "age": 56, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 682252, "exercisedValue": 0, "unexercisedValue": 436894}, {"maxAge": 1, "name": "Dr. Christopher John Kenney M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 774702, "exercisedValue": 0, "unexercisedValue": 4053263}, {"maxAge": 1, "name": "Dr. Matthew D. Ronsheim Ph.D.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelley  McClCoskey B.A.", "age": 64, "title": "Executive Vice President of Human Resources", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robin P. Sherrington Ph.D.", "age": 63, "title": "Executive Vice President of Strategy & Innovation", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 587028, "exercisedValue": 0, "unexercisedValue": 9907717}, {"maxAge": 1, "name": "Dr. James R. Empfield Ph.D.", "age": 63, "title": "Executive Vice President of Drug Discovery", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 323428, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Darren S. Cline M.B.A.", "age": 60, "title": "Chief Commercial Officer and Member of Executive Team", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 36.52, "open": 36.74, "dayLow": 36.145, "dayHigh": 38.055, "regularMarketPreviousClose": 36.52, "regularMarketOpen": 36.74, "regularMarketDayLow": 36.145, "regularMarketDayHigh": 38.055, "payoutRatio": 0.0, "beta": 1.172, "forwardPE": -10.668539, "volume": 668988, "regularMarketVolume": 668988, "averageVolume": 847144, "averageVolume10days": 718370, "averageDailyVolume10Day": 718370, "bid": 37.94, "ask": 38.1, "bidSize": 1, "askSize": 1, "marketCap": 2928478208, "fiftyTwoWeekLow": 26.74, "fiftyTwoWeekHigh": 46.0, "allTimeHigh": 50.99, "allTimeLow": 2.1, "priceToSalesTrailing12Months": 390.46378, "fiftyDayAverage": 35.745, "twoHundredDayAverage": 35.569824, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2449648128, "profitMargins": 0.0, "floatShares": 71595819, "sharesOutstanding": 77105799, "sharesShort": 7040555, "sharesShortPriorMonth": 6892652, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0913, "heldPercentInsiders": 0.0014300001, "heldPercentInstitutions": 1.1125, "shortRatio": 10.56, "shortPercentOfFloat": 0.1018, "impliedSharesOutstanding": 77253592, "bookValue": 8.24, "priceToBook": 4.6092234, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -278228000, "trailingEps": -3.55, "forwardEps": -3.56, "enterpriseToRevenue": 326.62, "enterpriseToEbitda": -7.764, "52WeekChange": -0.035306096, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 37.98, "targetHighPrice": 65.0, "targetLowPrice": 43.0, "targetMeanPrice": 54.94833, "targetMedianPrice": 55.0, "recommendationMean": 1.21053, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 18, "totalCash": 487544992, "totalCashPerShare": 6.323, "ebitda": -315496000, "totalDebt": 8715000, "quickRatio": 14.786, "currentRatio": 15.138, "totalRevenue": 7500000, "debtToEquity": 1.375, "revenuePerShare": 0.096, "returnOnAssets": -0.25518, "returnOnEquity": -0.37649, "grossProfits": -245127008, "freeCashflow": -149782000, "operatingCashflow": -229935008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -42.416, "financialCurrency": "USD", "symbol": "XENE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekLowChange": 11.24, "fiftyTwoWeekLowChangePercent": 0.42034405, "fiftyTwoWeekRange": "26.74 - 46.0", "fiftyTwoWeekHighChange": -8.02, "fiftyTwoWeekHighChangePercent": -0.17434783, "fiftyTwoWeekChangePercent": -3.5306096, "earningsTimestamp": 1754942400, "earningsTimestampStart": 1762804800, "earningsTimestampEnd": 1762804800, "earningsCallTimestampStart": 1754944200, "earningsCallTimestampEnd": 1754944200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.55, "epsForward": -3.56, "epsCurrentYear": -4.29491, "priceEpsCurrentYear": -8.843026, "fiftyDayAverageChange": 2.2350006, "fiftyDayAverageChangePercent": 0.06252625, "twoHundredDayAverageChange": 2.4101753, "twoHundredDayAverageChangePercent": 0.06775899, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Xenon Pharmaceuticals Inc.", "longName": "Xenon Pharmaceuticals Inc.", "exchange": "NGM", "messageBoardId": "finmb_565718", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.99781, "regularMarketPrice": 37.98, "corporateActions": [], "postMarketTime": 1758917404, "regularMarketTime": 1758916800, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1415197800000, "postMarketChangePercent": 0.0, "postMarketPrice": 37.98, "postMarketChange": 0.0, "regularMarketChange": 1.46, "regularMarketDayRange": "36.145 - 38.055", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 847144, "displayName": "Xenon Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]